|
⚲
|
| Keyboard |
| Calabro Joseph M
✚
|
|
|---|---|
| CIK # | 0001218834 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001218834] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Calabro Joseph M | |
| Mednax Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mednax Inc MD
Common Stock
|
2019-06-01 | Tax withheld | 14,729 | $24.66 | 363,217 |
|
Mednax Inc MD
Common Stock
|
2019-03-01 | Sell | 12,130 | $32.91 | 399,198 |
|
Mednax Inc MD
`Common Stock
|
2019-02-12 | Grant | 108,791 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2018-06-01 | Sell | 22,186 | $45.20 | 1,002,807 |
|
Mednax Inc MD
Common Stock
|
2018-03-01 | Grant | 92,149 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2017-06-01 | Grant | 67,398 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2017-06-01 | Sell | 23,327 | $55.00 | 1,282,985 |
|
Mednax Inc MD
Common Stock
|
2016-06-01 | Grant | 55,156 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2016-06-01 | Sell | 28,347 | $67.78 | 1,921,360 |
|
Mednax Inc MD
Common Stock
|
2015-06-03 | Sell | 70,153 | $70.52 | 4,947,190 |
|
Mednax Inc MD
Common Stock
|
2015-06-01 | Grant | 53,412 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2015-06-01 | Sell | 37,918 | $70.48 | 2,672,461 |
|
Mednax Inc MD
Common Stock
|
2014-06-02 | Sell | 38,228 | $56.98 | 2,178,231 |
|
Mednax Inc MD
Common Stock
|
2014-06-01 | Grant | 65,071 | $0.00 | |
|
Mednax Inc MD
Common Stock
|
2014-05-08 | Option exercise | 14,510 | $28.03 | 406,715 |
|
Mednax Inc MD
Stock Options (Right to Buy) · derivative
|
2014-05-08 | Option exercise | 14,510 | $28.03 | 406,715 |
|
Mednax Inc MD
Common Stock
|
2014-05-08 | Sell | 14,510 | $57.69 | 837,082 |
|
Mednax Inc MD
Stock Options (Right to Buy) · derivative
|
2014-05-07 | Option exercise | 62,500 | $27.72 | 1,732,500 |
|
Mednax Inc MD
Common Stock
|
2014-05-07 | Sell | 122,990 | $56.98 | 7,007,970 |
|
Mednax Inc MD
Common Stock
|
2014-05-07 | Option exercise | 62,500 | $27.72 | 1,732,500 |
| showing 20 of 41 most recent transactions | |||||